Impact of Multiphase ⁶⁸Ga-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors

Publisher： Karger

E-ISSN： 1423-0194|91|1|101-109

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.91, Iss.1, 2009-12, pp. : 101-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Combined ⁶⁸Ga-DOTANOC and ¹⁸FDG PET/CT in the Management of Patients with Pancreatic Neuroendocrine Tumors

Neuroendocrinology, Vol. 100, Iss. 4, 2014-10 ,pp. : 293-299

Karger

Access to resources Recommend Favorite

Peptide Receptor Radionuclide Therapy with ⁹⁰Y-DOTATOC and ¹⁷⁷Lu-DOTATOC in Advanced Neuroendocrine Tumors: Results from a Danish Cohort Treated in Switzerland

Neuroendocrinology, Vol. 93, Iss. 3, 2011-02 ,pp. : 189-196

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors

Neuroendocrinology, Vol. 90, Iss. 2, 2009-08 ,pp. : 203-208

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors

Neuroendocrinology, Vol. 105, Iss. 3, 2017-03 ,pp. : 245-254

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors

Neuroendocrinology, Vol. 103, Iss. 2, 2016-01 ,pp. : 153-171

Karger

Access to resources Recommend Favorite